178 related articles for article (PubMed ID: 22392075)
21. Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma.
Groot VP; Rezaee N; Wu W; Cameron JL; Fishman EK; Hruban RH; Weiss MJ; Zheng L; Wolfgang CL; He J
Ann Surg; 2018 May; 267(5):936-945. PubMed ID: 28338509
[TBL] [Abstract][Full Text] [Related]
22. Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival.
Nordby T; Hugenschmidt H; Fagerland MW; Ikdahl T; Buanes T; Labori KJ
Eur J Surg Oncol; 2013 Jun; 39(6):559-66. PubMed ID: 23498362
[TBL] [Abstract][Full Text] [Related]
23. Failure patterns in resected pancreas adenocarcinoma: lack of predicted benefit to SMAD4 expression.
Winter JM; Tang LH; Klimstra DS; Liu W; Linkov I; Brennan MF; DʼAngelica MI; DeMatteo RP; Fong Y; Jarnagin WR; Oʼreilly EM; Allen PJ
Ann Surg; 2013 Aug; 258(2):331-5. PubMed ID: 23360922
[TBL] [Abstract][Full Text] [Related]
24. Prognostication for recurrence patterns after curative resection for pancreatic ductal adenocarcinoma.
Ang A; Michaelides A; Chelala C; Ullah D; Kocher HM;
Ann Hepatobiliary Pancreat Surg; 2024 May; 28(2):248-261. PubMed ID: 38556877
[TBL] [Abstract][Full Text] [Related]
25. The canary in the coal mine: the growth of patient-derived tumorgrafts in mice predicts clinical recurrence after surgical resection of pancreatic ductal adenocarcinoma.
Thomas RM; Truty MJ; Kim M; Kang Y; Zhang R; Chatterjee D; Katz MH; Fleming JB
Ann Surg Oncol; 2015; 22(6):1884-92. PubMed ID: 25404477
[TBL] [Abstract][Full Text] [Related]
26. A prospective comparison of the prognostic value of tumor- and patient-related factors in patients undergoing potentially curative surgery for pancreatic ductal adenocarcinoma.
Jamieson NB; Denley SM; Logue J; MacKenzie DJ; Foulis AK; Dickson EJ; Imrie CW; Carter R; McKay CJ; McMillan DC
Ann Surg Oncol; 2011 Aug; 18(8):2318-28. PubMed ID: 21267785
[TBL] [Abstract][Full Text] [Related]
27. Impact of Preoperative Biliary Drainage on Long-Term Survival in Resected Pancreatic Ductal Adenocarcinoma: A Multicenter Observational Study.
Uemura K; Murakami Y; Satoi S; Sho M; Motoi F; Kawai M; Matsumoto I; Honda G; Kurata M; Yanagimoto H; Nishiwada S; Fukumoto T; Unno M; Yamaue H
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1238-46. PubMed ID: 26014151
[TBL] [Abstract][Full Text] [Related]
28. The significance of relative dose intensity in adjuvant chemotherapy of pancreatic ductal adenocarcinoma-including the analysis of clinicopathological factors influencing relative dose intensity.
Yabusaki N; Fujii T; Yamada S; Murotani K; Sugimoto H; Kanda M; Nakayama G; Koike M; Fujiwara M; Kodera Y
Medicine (Baltimore); 2016 Jul; 95(29):e4282. PubMed ID: 27442667
[TBL] [Abstract][Full Text] [Related]
29. Laparoscopic versus open pancreatic resection for ductal adenocarcinoma: separate propensity score matching analyses of distal pancreatectomy and pancreaticoduodenectomy.
Chen K; Pan Y; Huang CJ; Chen QL; Zhang RC; Zhang MZ; Wang GY; Wang XF; Mou YP; Yan JF
BMC Cancer; 2021 Apr; 21(1):382. PubMed ID: 33836678
[TBL] [Abstract][Full Text] [Related]
30. Neoadjuvant FOLFIRINOX for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis.
Choi JG; Nipp RD; Tramontano A; Ali A; Zhan T; Pandharipande P; Dowling EC; Ferrone CR; Hong TS; Schrag D; Fernandez-Del Castillo C; Ryan DP; Kong CY; Hur C
Oncologist; 2019 Jul; 24(7):945-954. PubMed ID: 30559125
[TBL] [Abstract][Full Text] [Related]
31. Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis.
Showalter TN; Rao AS; Rani Anne P; Rosato FE; Rosato EL; Andrel J; Hyslop T; Xu X; Berger AC
Ann Surg Oncol; 2009 Aug; 16(8):2116-22. PubMed ID: 19437078
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Value of Adjuvant Chemotherapy Following Pancreaticoduodenectomy in Elderly Patients With Pancreatic Cancer.
Shin SH; Park Y; Hwang DW; Song KB; Lee JH; Kwon J; Yoo C; Alshammary S; Kim SC
Anticancer Res; 2019 Feb; 39(2):1005-1012. PubMed ID: 30711988
[TBL] [Abstract][Full Text] [Related]
33. Long-term survival (superior to 20 years) after pancreaticoduodenectomy for pancreatic duct adenocarcinoma: report of two cases.
Naseef O; Adham M; Hervieu V; Le Borgne J; Partensky C
Hepatogastroenterology; 2008; 55(84):1110-1. PubMed ID: 18705340
[TBL] [Abstract][Full Text] [Related]
34. Association of Adjuvant Radiotherapy With Survival After Margin-negative Resection of Pancreatic Ductal Adenocarcinoma: A Propensity-matched National Cancer Database (NCDB) Analysis.
Kamarajah SK; Sonnenday CJ; Cho CS; Frankel TL; Bednar F; Lawrence TS; Nathan H
Ann Surg; 2021 Mar; 273(3):587-594. PubMed ID: 30817352
[TBL] [Abstract][Full Text] [Related]
35. Prospective assessment of resection margin status following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma after standardisation of margin definitions.
Pine JK; Haugk B; Robinson SM; Darne A; Wilson C; Sen G; French JJ; White SA; Manas DM; Charnley RM
Pancreatology; 2020 Apr; 20(3):537-544. PubMed ID: 31996296
[TBL] [Abstract][Full Text] [Related]
36. Assessment of pathologic response after preoperative chemoradiotherapy and surgery in pancreatic adenocarcinoma.
Moutardier V; Magnin V; Turrini O; Viret F; Hennekinne-Mucci S; Gonçalves A; Pesenti C; Guiramand J; Lelong B; Giovannini M; Monges G; Houvenaeghel G; Delpero JR
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):437-43. PubMed ID: 15380577
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological variables and risk factors for lung recurrence after resection of pancreatic ductal adenocarcinoma.
Asakura Y; Toyama H; Ishida J; Asari S; Terai S; Shirakawa S; Yamashita H; Shimizu T; Ogura Y; Matsumoto I; Gon H; Tsugawa D; Komatsu S; Kuramitsu K; Yanagimoto H; Kido M; Ajiki T; Fukumoto T
Asian J Surg; 2023 Jan; 46(1):207-212. PubMed ID: 35370072
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of preoperative prognostic factors in patients with resectable pancreatic ductal adenocarcinoma.
Izumo W; Higuchi R; Furukawa T; Yazawa T; Uemura S; Shiihara M; Yamamoto M
Scand J Gastroenterol; 2019 Jun; 54(6):780-786. PubMed ID: 31180790
[No Abstract] [Full Text] [Related]
39. Positive neck margin at frozen section analysis is a significant predictor of tumour recurrence and poor survival after pancreatodudenectomy for pancreatic cancer.
Crippa S; Guarneri G; Belfiori G; Partelli S; Pagnanelli M; Gasparini G; Balzano G; Lena MS; Rubini C; Doglioni C; Zamboni G; Falconi M
Eur J Surg Oncol; 2020 Aug; 46(8):1524-1531. PubMed ID: 32098733
[TBL] [Abstract][Full Text] [Related]
40. Long-term outcomes following en bloc resection for pancreatic ductal adenocarcinoma of the head with portomesenteric venous invasion.
Han S; Choi DW; Choi SH; Heo JS; Han IW; You YH
Asian J Surg; 2021 Jan; 44(1):313-320. PubMed ID: 32972828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
